Health Care · S&P 500

Bio-Techne

A life science reagent company making antibodies, proteins, and diagnostic tools for research. S&P 500 constituent. Sector: Health Care (Life Sciences Tools & Services). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.

TECH Updated Jul 11, 2026 2 AI consumers

Annual return · 2026-07-10'21+63.4%'22-35.7%'23-6.5%'24-6.2%'25-17.9%YTD+21.6%
Money in·
Bio-Techne~$1.2B
Money out·

Financials & Segments

  • Total revenue · ~$1.2B (FY2024)
  • Segments · Protein Sciences · Diagnostics & Genomics

Revenue from

No refined links yet.

Pays to

No refined links yet.


← All companiesMarkdown · JSON

For information only, not investment advice. Content on this site is generated by AI from verified, cross-checked sources and may contain errors.

© 2026 Willow Investments, Inc.Company value-chain data · contact@willowinvt.com